<DOC>
	<DOC>NCT00785239</DOC>
	<brief_summary>The purpose of this study is to create a patient registry to collect and analyze information on subjects treated with the CryoSpray Ablation™ System post-510K approval.</brief_summary>
	<brief_title>CryoSpray Ablation(tm)Thoracic Patient Registry</brief_title>
	<detailed_description>The proposed registry is a prospective, multi-center study of patients that are currently undergoing CryoSpray Ablation™. A maximum of 50 investigational sites will participate in this study. The study population consists of patients who are being treated with the CryoSpray Ablation™ System for thoracic diseases. Enrolled subjects must have a signed consent form for data collection.</detailed_description>
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Bronchitis</mesh_term>
	<mesh_term>Sarcoidosis</mesh_term>
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pulmonary Emphysema</mesh_term>
	<mesh_term>Bronchitis, Chronic</mesh_term>
	<criteria>Patients who are being treated with the CryoSpray Ablation™ System for lung and for thoracic diseases. Subjects with thoracic or airway obstructions and diseases who were not treated with the CryoSpray Ablation™ System. Subjects under the age of 18 years. Subjects unable to provide consent.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Malignant Airway Disease</keyword>
	<keyword>Benign Airway Disease</keyword>
	<keyword>Lung Cancer</keyword>
	<keyword>Emphysema</keyword>
	<keyword>Chronic Bronchitis</keyword>
	<keyword>COPD</keyword>
	<keyword>Asthma</keyword>
	<keyword>Sarcoidosis</keyword>
	<keyword>Mesothelioma</keyword>
	<keyword>CryoSpray Ablation</keyword>
	<keyword>Cryotherapy</keyword>
	<keyword>Cryospray</keyword>
	<keyword>Cryo</keyword>
</DOC>